Trump administration eyes end to subsidies in Medicare’s prescription drug plan

The president and his team already scrapped subsidies for ACA consumers. Now they’re also ending subsidies for millions of Medicare beneficiaries.

The Trump administration on Tuesday said it would move to end a Biden-era Medicare premium subsidy program, alleging it benefitted insurance companies more than enrollees.  As a result, Medicare Part D subsidies will expire at the end of the year and no longer be offered in 2027.  Medicare Part D is optional prescripti

The White House decision to end a Medicare drug subsidy plays into Democratic arguments ahead of the midterms.

Trump administration will end the Medicare Part D subsidy after 2026, raising concerns over higher drug plan premiums for millions of seniors in 2027.

The Part D Premium Stabilization Demonstration will expire after 2026, the CMS announced Tuesday.

The prescription drug benefit is used by millions of seniors.

The Part D Premium Stabilization Demonstration, which gave insurers billions to hold down drug premiums, will end after this year

The loss of the subsidy does not translate directly to how much premiums will rise, because companies that sell Medicare Part D drug coverage take into account many factors when setting rates.

Millions of older Americans could pay more for their prescription drug coverage next year.

Trump administration to end Medicare premium subsidy program  Reuters

Experts say this could mean that more seniors will switch to Medicare Advantage plans

The Trump administration intends to end a subsidy program that helped lower costs for Medicare drug plans, a move that could potentially raise monthly costs for older adults.

Exclusive | Trump Administration to End Medicare Drug Plan Subsidy  WSJ